Intranasal Drug Delivery Devices Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the Intranasal Drug Delivery Devices market size evolved in recent years?
The market size for intranasal drug delivery devices has seen robust growth in the past years. Its growth is projected to escalate from $60.27 billion in 2024 to $65.59 billion in 2025, representing a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this growth during the historic period include an increase in chronic respiratory diseases, patient compliance and preference, the ease of self-administration, applications in pediatrics, an expanding market for allergic rhinitis treatment, and a broader range of indications.
What are the predictions for the intranasal drug delivery devices market size in the coming years?
The market for intranasal drug delivery devices is set for significant expansion in the coming years, expected to reach a value of $92.05 billion in 2029, representing a compound annual growth rate (CAGR) of 8.8%. Factors behind this growth will be an aging population, heightened incidence of respiratory issues worldwide, growth in the use of these devices for neurological conditions, the rise of personalized medicine, preventive health efforts, and market expansion in developing economies. Key trends identified over the forecast period include innovations in formulation technologies, an increased emphasis on pediatric and geriatric applications, a shift towards self-administration devices and nasal powder inhalers, and the inclusion of biologics and peptides.
Get your intranasal drug delivery devices market report here!
What key factors are fueling the growth of the intranasal drug delivery devices market?
The anticipated rise in chronic diseases is predicted to spur on the expansion of the intranasal drug delivery devices market. Chronic diseases, which endure for a year or more and necessitate continuous medical intervention or impact daily life actions, or both, can be regulated using intranasal drug delivery mechanisms. These devices provide a simple, non-invasive way to apply treatments, facilitating quick absorption by targeting the drug straight to the affected area. For example, in June 2024, the National Health Service in the UK reported that the number of individuals in England who are at risk of type 2 diabetes increased by 549,000 in 2023. This takes the total populace with pre-diabetes registered with a GP to 3,615,330, marking a nearly 20% increase from 2022’s figure of 3,065,825. Thus, the rising occurrence of chronic diseases is propelling the intranasal drug delivery devices market even further. A marked increase in demand for non-invasive drug delivery systems is forecasted to boost the expansion of the intranasal drug delivery device market. Non-invasive drug delivery entails the administration of pharmaceuticals into the body without disturbing the skin or mucous membranes. Intranasal drug delivery devices provide a simple and effective way to deliver drugs via the nasal route. These devices capitalise on the nose’s extensive vascular network and quick absorption rates, which enhance drug bioavailability, patient compliance, while also reducing the need for invasive procedures. For example, the Aesthetic Society in the U.S. observed in August 2023 that non-invasive treatments, such as body contouring, skin treatment, toxins, and microneedling expanded at rates of 31%, 26%, 24%, and 23%, respectively, in 2022. Therefore, the increasing demand for non-invasive drug delivery systems is a leading driver of the intranasal drug delivery device market’s growth.
How is the global intranasal drug delivery devices market divided into key segments?
The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device
2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device
3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs
4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp
Who are the key firms paving the way for growth in the intranasal drug delivery devices market?
Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation
Which trends are expected to transform the intranasal drug delivery devices market?
Major pharmaceutical firms in the nasal drug delivery technology market are focusing on the innovation of new and enhanced products to maintain their market standing by providing alternative drug administration methods. For example, in January 2023, US-based AptarGroup, Inc., a pharmaceutical and drug delivery corporation, unveiled APF Futurity, the first recyclable, metal-free, multidose nasal spray, created for nasal saline and other similar over-the-counter (OTC) formulations. APF Futurity is created from polyolefin substances and excludes any metal elements or recycling impediments, encouraging better-quality recycling materials by reducing the necessity for separation in recycling streams. This product stands out due to its designed for recyclability; it’s a highly recyclable nasal spray pump with Class AA certification from cyclos-HTP, approved for European recycling streams.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13463
What regions are contributing significantly to the growth of the intranasal drug delivery devices market?
North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
ENT Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ent-devices-global-market-report
Fetal And Neonatal Monitoring Devices Global Market Report 2024
Hematology Diagnostic Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
